Diagnostic gaps in light microscopy for malaria case management and control in Dilla Zuria Health Facility, southern Ethiopia Authors: Alayu Bogale, Samuel Tefera, Asaye Mitiku, Zerihun Solomon, Tadesse Misganaw Published: 2026 ABSTRACT Malaria misdiagnosis has important clinical and public health consequences, including inappropriate treatment, missed infections, ongoing transmission, and weakened malaria control efforts. This study aimed to identify light-microscope misdiagnoses that may affect malaria case management and control efforts. A single-gate design study was conducted among 474 cases attending Dilla Zuria Health Facility. Venous blood samples were examined by light microscopy and subjected to a qPCR assay, which detects Plasmodium falciparum and Plasmodium vivax infections. The level of misdiagnosis, determined using qPCR as the reference standard, is summarized with descriptive statistics. Diagnostic performance metrics, including sensitivity, specificity, predictive values, accuracy, and kappa statistics, were calculated. Using qPCR as the confirmatory reference, the variation between onsite light microscopic diagnoses and qPCR was 24.7% (95/384) for positive cases and 18.8% (17/90) for negative cases. Moreover, the variation documented between onsite light microscopic diagnoses of P. falciparum was 21% (48/228) compared with qPCR, it was 28.3% (32/113) for P. vivax, and 34.8% (15/43) for P. falciparum and P. vivax mixed infection. Notably, 18.8% of microscopy-negative cases were qPCR-positive, possibly due to submicroscopic infections, inadequately prepared blood smears, or incorrectly read blood smears. Malaria diagnosis still relies on microscopy, but low-density and mixed infections are often missed, leading to misdiagnosis and continued transmission. Structured, competency-based, and regular training combined with robust quality assurance is essential to enhance diagnostic accuracy, optimize malaria case management, and support Ethiopia’s ongoing efforts toward malaria control.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-56354-3. Introduction Malaria is a serious public health issue that puts millions of people at risk. The disease remains a major global health challenge, with 282 million cases and 610,000 deaths reported in 2024, marking a slight increase from 2023 (263 million cases and 597, 000 malaria deaths worldwide)1. More than 7.3 million malaria cases and 1157 deaths have been reported in Ethiopia in 2024, according to the WHO, nearly twice as many as in 2023. Ethiopia is now one of the highest-burden countries in East Africa. Malaria remains a significant challenge to the country’s health care system, which has been further strained by previous and ongoing conflicts1 Malaria poses a major economic burden in Ethiopia, costing over $200 million annually, about 10% of the country’s total health expenditure2. A prompt and accurate diagnosis is crucial for directing the right course of treatment, reducing side effects, and stopping the spread of the disease. Before starting therapy, parasitological confirmation by light microscopy or rapid diagnostic tests (RDTs) is required by the national malaria treatment policy3. Light microscopy of blood films is the routine method for malaria diagnosis in clinical settings; however, it is susceptible to misdiagnosis due to technical, human, and biological factors. Limited technical expertise, challenges in detecting low-density parasitemia or mixed infections, and weak quality assurance systems lead to misdiagnosis4. Such misdiagnosis undermines malaria control efforts by causing inappropriate case management or incorrect treatment due to missed infections. Although quality assurance measures such as personnel training, refresher courses, and microscopy standardization are implemented to minimize errors, misdiagnosis remains common in many health facilities5, including Dilla Zuria, indicating the need for sustained capacity strengthening and improved diagnostic oversight. In addition to negatively affecting clinical outcomes, these misdiagnoses also contribute to the continued transmission within the community. In the southern part of Ethiopia, specifically in Hawassa city health facilities, a study assessing the quality of malaria microscopy found a significant level of misdiagnosis. Of the 306 malaria slides assessed, only 54% were correctly read. The most common errors were the inability to detect a malaria infection (47%), misidentification of the infecting malaria species (35%), and incorrect parasite density calculations (18%). In a mixed Plasmodium falciparum/Plasmodium vivax (Pf/Pv) sample, only 18% of laboratory technicians made a correct diagnosis in identifying both Pf/Pv species. In the Plasmodium negative sample 45(88.2%) of participants scored (no parasites observed)6. Although accurate diagnosis is a key component of malaria control, there is still a scarcity of empirical evidence on the magnitude of misdiagnosis and its operational implications in health facilities such as Dilla Zuria7. There is also limited evidence in the Dilla Zuria district comparing microscopy with qPCR using an enriched design. This study aimed to assess malaria misdiagnosis and discuss its implications for malaria control efforts at three health centers in Dilla Zuria District in Southern Ethiopia. The findings inform or guide the development of recommendations to address diagnostic gaps, thereby strengthening malaria diagnostic systems and improving the effectiveness of control initiatives in the study area. Methodology Study area A facility-based study was conducted across three health centers at Oda Ya’a, Haroressa, and Chichu, located in urban and semi-urban areas of Dilla Zuria District, Gedeo Zone, and Southern Ethiopia. It is 360 km from Addis Ababa, Ethiopia’s capital city, and has a longitude and latitude of 6° 24′ 30′′ N 38° 18′ 30′′ E with an elevation of 1570 m above sea level. The zone has two city administrations and eight woredas. The study was conducted in urban (Oda Ya’a and Haroressa health center) and semi-urban (Chichu health center) areas of Gedeo Zone health facilities. The Dilla Zuria has an average annual temperature of 21 °C that ranges from 12.6 to 30 °C. It experiences a short rainy season from March to May, contributing to 30% of the total rainfall, and a long rainy season from July to October, which accounts for over 60% of the total rainfall. The study area comprised the following health centers: Haroressa Health Centre, Oda Ya’a Health Centre, and Chichu Health Centre. The standard diagnostic tool for Plasmodium detection was microscopy. The first-line treatment for uncomplicated P. falciparum malaria in three health centers in Dilla Zuria District is artemether-lumefantrine (AL). For P. vivax malaria, the first-line treatment typically includes chloroquine followed by primaquine for radical cure to prevent relapse. Malaria transmission in the zone is seasonal, with a peak from September to November. Based on the 2024/2025 report from the zonal health department, malaria prevalence reached as high as 37.4% (63,340/169,164) with facility-based case proportion. According to health center records, the proportion of infections was 55.74% for P. falciparum and 44.26% for P. vivax. The map of the study area is shown in Fig. 1.Fig. 1Map of the study area in Dilla Zuria health facility. Source: Map produced by using ARCMAP 10.8 Version. Map of the study area in Dilla Zuria health facility. Source: Map produced by using ARCMAP 10.8 Version. Study period and Study design A health facility-based single-gate design was conducted from October 2024 to December 2024. Study population The study enrolled individuals of all ages who presented to the health facility during the study period with suspected malaria. The study population comprised patients exhibiting malaria-related clinical manifestations, including fever, headache, chills, sweating, malaise, fatigue, nausea, vomiting, muscle or joint pain, loss of appetite, and dizziness8, who sought care at Dilla Zuria Health Facility. Participants were consecutively recruited based on clinical suspicion of malaria and fever, were requested to undergo blood film examination, and provided written informed consent. Patients who were critically ill and unable to provide blood samples were excluded from the study. Sample size We used the sample size calculation methods of Buderer et al.9. In this method, we first calculated the True positive (TP) plus false negative (FN) for sensitivity and the true negative (TN) plus false positive (FP) for specificity through the following equation:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mathrm{TP}} + {\mathrm{FN}} = {\text{ Z}}^{{2}} \times {\text{se }}\left( {{1} - {\mathrm{se}}} \right)/{\mathrm{W}}^{{2}} \quad {\mathrm{and}}\quad {\mathrm{TN}} + {\mathrm{FP}} = {\text{ Z}}^{{2}} \times {\text{sp }}\left( {{1} - {\mathrm{sp}}} \right)/{\mathrm{W}}^{{2}}$$\end{document}where Z, the normal distribution value, is set to 1.96 as corresponding with the 95% confidence interval (CI), W, the maximum acceptable width of the 95% CI, is set to 5%, and the expected sensitivity of 90% and specificity of 95% are defined based on the estimates from previous studies done in Korea10. The next step was to calculate the sample size (N) required for sensitivity and for specificity through the following equations:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\text{N }}\left( {{\mathrm{se}}} \right) \, = {\text{ TP}} + {\mathrm{FN}}/{\mathrm{P}}\quad {\mathrm{and}}\quad {\text{N }}\left( {{\mathrm{sp}}} \right) \, = {\text{ TN}} + {\mathrm{FP}}/{1} - {\mathrm{P}}$$\end{document}where P is the prevalence of malaria. Taking the prevalence of symptomatic malaria of 36% in Woreta town, Amhara region, Northwest Ethiopia11 a minimum of 384 for sensitivity and 110 samples for specificity was required. The highest number of microscopically positive study participants was 384 because of sensitivity. Based on this calculation, the study sample size was 474 samples, comprising 384 microscopy-malaria-positive and 90 microscopy-malaria-negative samples. Blood sample collection and species identification Using a single-use sterile syringe, one milliliter of venous blood was drawn and placed in a tube containing ethylenediaminetetraacetic acid12. Thin (2 µL) and thick (6 µL) blood films were prepared on a single slide. The thin smear was fixed with methanol after air drying, and both smears were stained with 10% Giemsa for 10 min. Slides were examined by trained laboratory technologists using 100 × oil immersion microscopy. A slide was considered negative after examining 100 fields without detecting parasites13. Parasite density was estimated on thick blood films by counting asexual parasites against 200 or 500 white blood cells (WBCs), depending on parasite density14. The number of parasites per µL of blood was calculated by dividing the parasite count by the number of WBCs counted and multiplying by an assumed WBC count of 8000/µL15. A total of 956 blood smears were examined by onsite microscopists and reported 384 positive and 90 negative cases, and the expert microscopist worked only on the 474 cases to confirm parasite presence or absence, determine species, and quantify parasite density. The expert microscopist was qualified with an MSc in Medical Parasitology, had more than 10 years of experience, and had received advanced training and certification in malaria laboratory diagnosis and quality assurance from the Ethiopian Public Health Institute, in collaboration with the UK Health Security Agency and ICAP, Columbia University. For each sample, approximately 20 μl of blood was applied to each of three separate spots on a Whatman™ 3MM (VWR®) filter paper, yielding a total volume of 60 μl per card, which was subsequently used for quantitative PCR validation. The blood spots were air-dried to generate dried blood spots (DBS), which were subsequently stored in zip-locked plastic bags containing silica gel16. The samples were subsequently transported to the Armauer Hansen Research Institute, Federal Ministry of Health Research Institute, Addis Ababa, Ethiopia, for molecular analysis. Plasmodium parasite detection by quantitative PCR DNA extraction from DBS Genomic DNA was extracted from dried blood spots (DBS) using the NucleoMag® Blood kit following the manufacturer’s instructions and AHRI SOPs. Briefly, 3 mm DBS punches were incubated overnight at 56 °C in ATL buffer with Proteinase K. DNA extraction was then performed using the KingFisher Flex system with lysis, binding, washing, and elution steps to obtain purified DNA17. Identification of malaria parasites Multiplex quantitative PCR Species confirmation of P. falciparum and P. vivax was performed using an in-house TaqMan probe-based qPCR assay targeting species-specific regions of the 18S rRNA gene. FAM and Texas Red fluorescent probes were used for the detection of P. falciparum and P. vivax, respectively. Appropriate positive and negative controls were included in each run for quality assurance. Amplification was performed in a 20 µL reaction volume under standard cycling conditions consisting of initial denaturation at 95 °C for 3 min, followed by 45 cycles at 94 °C for 15 s and 60 °C for 1 min18. Data management and analysis The questionnaire captured demographic information, including participants’ age and sex. The questionnaires were completed through face-to-face interviews conducted with each study participant. Following data collection, laboratory results were entered into Microsoft Excel and subsequently analyzed using SPSS version 25 for statistical evaluation. The level of misdiagnosis, determined using qPCR as the reference standard, was summarized using descriptive statistics. A 2 × 2 contingency table was used to calculate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy. Agreement between onsite microscopy and qPCR was assessed using the Kappa (κ) statistic. In this study, diagnostic performance indicators were calculated using standard definitions. These measures were calculated using the corresponding 2 × 2 contingency tables generated from the study data, which are shown in Table 1 below. For species-specific diagnostic performance, separate 2 × 2 contingency tables were constructed using a one-vs-all analytical approach. For each Plasmodium species, samples positive for the target species by the reference standard (qPCR) were classified as true positives. The corresponding negative comparator group comprised all non-target outcomes, including samples positive for other Plasmodium species (both single and mixed infections) as well as qPCR-negative samples.\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\text{Sensitivity }} = {\text{ TP }}/ \, \left( {{\text{TP }} + {\text{ FN}}} \right) \times {1}00.$$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\text{Specificity }} = {\text{ TN }}/ \, \left( {{\text{FP }} + {\text{ TN}}} \right) \times {1}00.$$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mathrm{Positive}}\;{\mathrm{predictive}}\;{\text{value }} = {\text{ TP }}/ \, \left( {{\text{TP }} + {\text{ FP}}} \right) \times {1}00.$$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mathrm{Negative}}\;{\mathrm{predictive}}\;{\mathrm{value}} = {\mathrm{TN}}/\left( {{\mathrm{FN}} + {\mathrm{TN}}} \right) \times {1}00$$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mathrm{Accuracy}} = {\mathrm{TP}} + {\mathrm{TN}}/\left( {{\mathrm{TP}} + {\mathrm{FP}} + {\mathrm{FN}} + {\mathrm{TN}}} \right) \times {1}00$$\end{document}Table 1Diagnostic accuracy of the malaria microscopy compared with qPCR.qPCR (References)PositiveNegativeTotalMicroscopy PositiveTPFPTP + FP NegativeFNTNFN + TN TotalTP + FNFP + TNTP + FP + FN + TNwhere TP True Positives, TN True Negatives, FP False Positives, FN False Negatives. Table 1Diagnostic accuracy of the malaria microscopy compared with qPCR.qPCR (References)PositiveNegativeTotalMicroscopy PositiveTPFPTP + FP NegativeFNTNFN + TN TotalTP + FNFP + TNTP + FP + FN + TNwhere TP True Positives, TN True Negatives, FP False Positives, FN False Negatives. Diagnostic accuracy of the malaria microscopy compared with qPCR. where TP True Positives, TN True Negatives, FP False Positives, FN False Negatives. PCR was used as the reference standard to classify cases as true positive or true negative. Sensitivity, specificity, PPV, and NPV were calculated based on PCR results. The Kappa (κ) statistic was used to measure the level of agreement between microscopy and qPCR. It is calculated using the formula:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\kappa = \frac{{P_{o} - P_{e} }}{{1 - P_{e} }}$$\end{document}where \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$P_{o}$$\end{document} is the observed proportion of agreement between the two methods. \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$P_{e}$$\end{document} is the expected proportion of agreement by chance, calculated from the marginal probabilities of each method classifying positive and negative cases. To compute \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$P_{e}$$\end{document}, we have multiplied the probabilities that each method classifies samples as positive or negative, then summed these probabilities for positive and negative agreement. Interpretation of κ:< 0: Poor agreement (less than chance)0.00–0.20: Slight agreement0.21–0.40: Fair agreement0.41–0.60: Moderate agreement0.61–0.80: Substantial agreement0.81–1.00: Almost perfect or perfect agreement < 0: Poor agreement (less than chance) < 0: Poor agreement (less than chance) 0.00–0.20: Slight agreement 0.00–0.20: Slight agreement 0.21–0.40: Fair agreement 0.21–0.40: Fair agreement 0.41–0.60: Moderate agreement 0.41–0.60: Moderate agreement 0.61–0.80: Substantial agreement 0.61–0.80: Substantial agreement 0.81–1.00: Almost perfect or perfect agreement 0.81–1.00: Almost perfect or perfect agreement Kappa statistics were used as a robust measure of concordance between microscopy and qPCR. Results Socio-demographic characteristics Across the three health centers, 956 individuals were screened during the study period, yielding 384 microscopy-positive and 572 microscopy-negative cases. From these, all 384 positive samples and a subset of 90 negative samples were selected for qPCR analysis. Females accounted for 51.9% (246/474) of the study population, with the median age of the study participants being 24 (range between 2 and 78 years). The socio-demographic characteristics of participants involved in the onsite microscopy and qPCR studies are presented as follows (Table 2).Table 2Malaria suspected cases, onsite microscopically and qPCR confirmed cases in Dilla Zuria Health facility, Southern Ethiopia, from October to December 2024, N = 474.VariableOn-site Microscopy result n, (%)qPCR result n, (%)PfPvMixNegTotalPfPvMixNegTotalSex Male116 (24.5)55 (11.6)15 (3.2)42 (8.8)228102 (21.5)55 (11.6)23 (4.8)48 (10.1)228 Female112 (23.6)58 (12.2)28 (5.9)48 (10.1)246101 (21.3)56 (11.8)37 (7.6)52 (10.9)246 Total228 (48.1)113 (23.8)43 (9.0)90 (18.9)474203 (42.8)111 (23.4)60 (12.6)100 (21.1)474Age 1–1471 (14.9)25 (5.3)16 (3.4)3 (0.60)11559 (12.4)25 (5.30)21 (4.4)10 (2.1)115 > 15157 (33.1)88 (18.5)27 (5.7)87 (18.4)359144 (30.3)86 (18.1)39 (8.2)90 (18.9)359 Total228 (48.1)113 (23.8)43 (9.0)90 (18.9)474203 (42.8)111 (23.4)60 (12.6)100 (21.1)474Pf- Plasmodium falciparum, Pv-Plasmodium vivax, Mix-Mixed infection (Pf + Pv), Neg-Negative cases, qPCR- quantitative polymerase chain reaction. Percentages are calculated using the total sample size (n = 474). Table 2Malaria suspected cases, onsite microscopically and qPCR confirmed cases in Dilla Zuria Health facility, Southern Ethiopia, from October to December 2024, N = 474.VariableOn-site Microscopy result n, (%)qPCR result n, (%)PfPvMixNegTotalPfPvMixNegTotalSex Male116 (24.5)55 (11.6)15 (3.2)42 (8.8)228102 (21.5)55 (11.6)23 (4.8)48 (10.1)228 Female112 (23.6)58 (12.2)28 (5.9)48 (10.1)246101 (21.3)56 (11.8)37 (7.6)52 (10.9)246 Total228 (48.1)113 (23.8)43 (9.0)90 (18.9)474203 (42.8)111 (23.4)60 (12.6)100 (21.1)474Age 1–1471 (14.9)25 (5.3)16 (3.4)3 (0.60)11559 (12.4)25 (5.30)21 (4.4)10 (2.1)115 > 15157 (33.1)88 (18.5)27 (5.7)87 (18.4)359144 (30.3)86 (18.1)39 (8.2)90 (18.9)359 Total228 (48.1)113 (23.8)43 (9.0)90 (18.9)474203 (42.8)111 (23.4)60 (12.6)100 (21.1)474Pf- Plasmodium falciparum, Pv-Plasmodium vivax, Mix-Mixed infection (Pf + Pv), Neg-Negative cases, qPCR- quantitative polymerase chain reaction. Percentages are calculated using the total sample size (n = 474). Malaria suspected cases, onsite microscopically and qPCR confirmed cases in Dilla Zuria Health facility, Southern Ethiopia, from October to December 2024, N = 474. Pf- Plasmodium falciparum, Pv-Plasmodium vivax, Mix-Mixed infection (Pf + Pv), Neg-Negative cases, qPCR- quantitative polymerase chain reaction. Percentages are calculated using the total sample size (n = 474). Species detection by onsite microscopy, expert microscopy, and qPCR On-site microscopy reported slightly higher detections of P. falciparum (228) and P. vivax (113) compared with both expert microscopy (212P.f and 104P.v) and qPCR (203P.f and 111P.v), indicating a possible tendency toward over-diagnosis at the facility level. In contrast, expert microscopy identified more mixed infections than on-site microscopy, although still fewer than those detected by qPCR. As the most sensitive diagnostic method, qPCR yielded the highest number of mixed-species infections (60), highlighting its superior ability to identify concurrent Plasmodium infections that may be missed by routine onsite microscopy (43) and expert microscopy (55) approaches. The comparative diagnostic performance is illustrated in Fig. 2. In comparison, expert microscopy showed discrepancies of 9 cases for P. falciparum (212 detected by expert microscopy and 203 detected by qPCR), 7 for P. vivax (104 detected by expert microscopy and 111 detected by qPCR), 5 for mixed infections (55 detected by expert microscopy and 60 detected by qPCR), and 3 for negative (103 negative cases detected by expert microscopy and 100 negative cases detected by qPCR) was classified relative to qPCR. These findings are summarized in Fig. 2.Fig. 2Comparative diagnosis of malaria by onsite microscopy, expert microscopy, and qPCR, N = 474. Comparative diagnosis of malaria by onsite microscopy, expert microscopy, and qPCR, N = 474. Of the 384 malaria-positive infections detected by onsite microscopy, 371 were confirmed by expert microscopy and 374 by qPCR. Using qPCR as the reference standard, on-site microscopy recorded 10 additional positive cases and 3 fewer positives compared with expert microscopy. Using qPCR as the reference method, the differences between on-site microscopy and qPCR were 25 cases for P. falciparum (228 detected by onsite microscopy and 203 detected by qPCR), 2 for P. vivax (113 detected by onsite microscopy and 111 detected by qPCR), 17 for mixed infections (43 detected by onsite microscopy and 60 detected by qPCR) and for negative results (90 negative cases detected by onsite microscopy and 100 negative instances detected by qPCR). These findings are presented in Fig. 3.Fig. 3PCR confirmation of microscopic diagnosis, N = 474. PCR confirmation of microscopic diagnosis, N = 474. Plasmodium parasites diagnosis by onsite microscopy and qPCR Among the 384 microscopy-confirmed malaria-positive cases, 59.4% were P. falciparum mono-infections, 29.4% were P. vivax mono-infections, and 11.2% were mixed infections. qPCR revealed notable discordance with microscopy, reclassifying several mono-infections as mixed infections or alternate species, while some cases were qPCR-negative. Additionally, qPCR detected P. falciparum and P. vivax infections in 18.9% (17/90) of microscopy-negative samples, indicating that microscopy missed submicroscopic infections, as shown in Fig. 3. Using qPCR as a confirmatory reference, the variation between microscopic diagnoses and qPCR was 24.7% (95/384) for positive cases and 18.8% (17/90) for negative cases. Moreover, the difference documented between microscopic diagnoses of P. falciparum was 21% (48/228) compared with qPCR, it was 28.3% (32/113) for P. vivax, and 34.8% (15/43) for P. falciparum and P. vivax mixed infection. Comparison of malaria onsite microscopy versus the qPCR technique The sensitivity of onsite light microscopy in the detection of P. falciparum was 88.67 (83.49 to 92.68), and its specificity was 82.29 (77.21 to 86.64). The reported 94.3% accuracy between microscopy and qPCR indicates that these two diagnostic methods agreed on the malaria infection status (accurately identify TP and TN) for approximately 94 out of every 100 samples tested. For P. vivax, the sensitivity of microscopy was 72.97 (63.72 to 80.96) and the specificity was 91.18 (87.78 to 93.89) using qPCR as a reference. Considering qPCR as a reference, the sensitivity of the onsite light microscope to detect P. falciparum and P. vivax mixed infection was low, 46.67 (33.67 to 60.00), but its specificity was 96.38 (94.01 to 97.96). A substantial degree of agreement between qPCR and onsite light microscopy was demonstrated, with a kappa value of 0.80916. The species-level detection agreement between qPCR and onsite light microscopy was 0.67626, indicating a moderate level of agreement. The findings of the diagnostic evaluation result were presented in Table 3.Table 3Performance of onsite light microscope in diagnosis of malaria compared to qPCR, Dilla Zuria health facility, Southern Ethiopia, N = 474.Plasmodium speciesqPCRSensitivity (95% CI)Specificity (95% CI)PPV (95%CI)NPV (95% CI)Accuracy (95% CI)Kappa value + ve−veTotalOnsite Microscopy vs qPCR Overall +ve3741038495.65 (93.13 to 97.15)87.95 (78.96 to 94.07)97.40 (95.43 to 98.53)81.11 (72.82 to 87.31)94.30 (91.82 to 96.21)0.80916 −ve177390 P. falciparum +ve1804822888.67 (83.49 to 92.68)82.29 (77.21 to 86.64)78.95 (74.28 to 82.96)90.65 (86.79 to 93.47)85.02 (81.49 to 88.11)0.69878 −ve23223246 P. vivax +ve813211372.97 (63.72 to 80.96)91.18 (87.78% to 93.89)71.68 (64.08 to 78.22)91.69 (89.03 to 93.75)89.92 (83.55 to 89.82)0.63759 −ve30331361 Mixed infection +ve28154346.67 (33.67 to 60.00)96.38 (94.01 to 97.96)65.12 (51.46 to 76.67)92.58 (90.77 to 94.05)90.08 (87.03 to 92.62)0.48976 −ve32399431qPCR quantitative polymerase chain reaction, CI confidence interval, PPV positive predictive value, NPV negative predictive value. Accuracy, PPV, and NPV are calculated in this enriched sample and may not directly represent performance among all 956 suspected cases. Table 3Performance of onsite light microscope in diagnosis of malaria compared to qPCR, Dilla Zuria health facility, Southern Ethiopia, N = 474.Plasmodium speciesqPCRSensitivity (95% CI)Specificity (95% CI)PPV (95%CI)NPV (95% CI)Accuracy (95% CI)Kappa value + ve−veTotalOnsite Microscopy vs qPCR Overall +ve3741038495.65 (93.13 to 97.15)87.95 (78.96 to 94.07)97.40 (95.43 to 98.53)81.11 (72.82 to 87.31)94.30 (91.82 to 96.21)0.80916 −ve177390 P. falciparum +ve1804822888.67 (83.49 to 92.68)82.29 (77.21 to 86.64)78.95 (74.28 to 82.96)90.65 (86.79 to 93.47)85.02 (81.49 to 88.11)0.69878 −ve23223246 P. vivax +ve813211372.97 (63.72 to 80.96)91.18 (87.78% to 93.89)71.68 (64.08 to 78.22)91.69 (89.03 to 93.75)89.92 (83.55 to 89.82)0.63759 −ve30331361 Mixed infection +ve28154346.67 (33.67 to 60.00)96.38 (94.01 to 97.96)65.12 (51.46 to 76.67)92.58 (90.77 to 94.05)90.08 (87.03 to 92.62)0.48976 −ve32399431qPCR quantitative polymerase chain reaction, CI confidence interval, PPV positive predictive value, NPV negative predictive value. Accuracy, PPV, and NPV are calculated in this enriched sample and may not directly represent performance among all 956 suspected cases. Performance of onsite light microscope in diagnosis of malaria compared to qPCR, Dilla Zuria health facility, Southern Ethiopia, N = 474. qPCR quantitative polymerase chain reaction, CI confidence interval, PPV positive predictive value, NPV negative predictive value. Accuracy, PPV, and NPV are calculated in this enriched sample and may not directly represent performance among all 956 suspected cases. Discussion This study evaluated the extent of misdiagnosis associated with onsite microscopy by using qPCR as the reference method for the identification of Plasmodium species in the Dilla Zuria health facility of Southern Ethiopia. Overall diagnostic agreement between microscopy and qPCR was high (94.3%), indicating substantial concordance between the two methods. The overall agreement between the two methods, using qPCR as the reference technique, suggests a reasonable level of concordance (κ = 0.80916). Although microscopy remains the most used diagnostic technique for malaria in most endemic areas due to its low cost and ease of use, our results demonstrate notable distinctions from the more sensitive qPCR method19. On-site microscopy generally shows lower accuracy in parasite detection and species identification compared to expert microscopy and qPCR. The data indicate that onsite microscopists face challenges in accurately detecting malaria parasites, especially in low-density and mixed infections, often resulting in species misclassification or missed infections. Expert microscopy, by contrast, provides more reliable species identification and parasite density counts when compared to an onsite microscopist. Microscopy demonstrated comparable performance to qPCR at high parasite densities. The diagnostic advantage of qPCR became more apparent at low parasite densities. The parasite count categories reveal that onsite microscopy parasitemia readings frequently deviate from those of experts, particularly at lower parasite densities, reflecting differences in skill and experience. The microscopy results for P. vivax showed a sensitivity of 72.97% and a specificity of 91.18%. The lower sensitivity can be a result of the usually low parasitemia observed in P. vivax infections, which makes light microscopy detection more difficult20,21. Research from Asia and Latin America has shown similar patterns, with P. falciparum being more commonly identified by microscopy than P. vivax22,23. For microscopy, the biggest problem is detecting mixed infections. While specificity remained high (96.38%), sensitivity was very low (46.67%). The low sensitivity for detecting mixed infections is likely due to the dominance of one species and low parasitemia of the other, which can obscure the presence of the less abundant species and hinder its detection by microscopy24. This results in microscopists misclassifying mixed infections as pure infections. Misdiagnosing P. falciparum/P. vivax mixed infections as mono-infections leads to inappropriate treatment, treatment failure, and P. vivax malaria episode relapses. In contrast, when P. vivax is correctly identified in mixed infections and a radical cure is provided, relapse episodes are substantially reduced or prevented. Species-level misclassification was common. For instance, 10.5% of onsite microscopy-confirmed P. falciparum mono-infections were found to be mixed infections by qPCR, and 4.8% were actually P. vivax. Similarly, 10.6% of P. vivax diagnoses were actually P. falciparum. These results highlight the shortcomings of microscopy in species differentiation, particularly in situations with low parasitemia and staff competence20,25,26. The high negative predictive values (≥ 81% for P. falciparum and P. vivax, calculated among 474 samples, calculated in this enriched sample, and may not directly represent performance among all 956 suspected cases) indicate that microscopy can generally be reliable when there is actually no infection, although 18.8% of microscopy-negative cases were found to be positive by qPCR. This might be due to submicroscopic infections, suboptimal slide preparation, inadequate staining, and limited technician experience/training. This aligns with previous findings that submicroscopic infections are relatively common in endemic settings27, acting as a hidden reservoir fueling ongoing malaria transmission in the community25,28. In the absence of precise laboratory diagnostics, false-negative results may lead to untreated malaria cases, potentially resulting in severe morbidity or mortality. Such misdiagnosis can undermine clinician confidence in laboratory findings and reduce trust within affected communities. Conversely, false-positive results carry significant risks as well; febrile patients with non-malarial illnesses may be erroneously diagnosed with malaria, thereby delaying appropriate treatment for the true etiology, which can also have fatal consequences. Additionally, misdiagnosis invites unwarranted prescription of costly antimalarial medications, unnecessarily exposing patients to potential drug toxicity and imposing avoidable burdens on both individuals and healthcare systems. Our findings are consistent with prior studies in Ethiopia and other malaria-endemic regions, which report high sensitivity of microscopy for P. falciparum, moderate sensitivity for P. vivax, and poor detection of mixed infections29. These limitations highlight the importance of incorporating more sensitive molecular tools, such as qPCR and ultrasensitive RDTs, for surveillance, elimination programs, and in situations where precise species identification is critical for case management(31). However, in resource-limited settings, strengthening microscopy through refresher training, quality assurance programs(32), and integration with ultrasensitive RDTs(33) could mitigate some of these challenges. These findings underscore the need to prioritize strengthening routine diagnostic systems through targeted training and retraining of microscopists, strict adherence to WHO diagnostic standards, implementation of comprehensive internal and external quality assurance schemes, and the deployment of highly sensitive RDTs where appropriate. Given its higher cost, technical complexity, longer turnaround time, and demanding quality assurance requirements, qPCR has limited feasibility in routine clinical case management in settings such as Ethiopia. Instead, its role is better suited to targeted surveillance, operational research, and the monitoring of parasite and vector resistance, where it can complement routine diagnostics and inform evidence-based malaria control strategies. This study has some limitations that should be considered when interpreting the findings. First, although qPCR was used as the reference standard for confirmation, the volume of blood used for extraction and the type of sample (DBS) also affect our results. Secondly, the study did not evaluate rapid diagnostic tests (RDTs) in parallel, which could have provided a more comprehensive comparison of available diagnostic tools in the local context. Conclusion This study highlights that while light microscopy remains a widely used diagnostic tool in Dilla Zuria health facilities, it has notable limitations in accurately identifying Plasmodium species and detecting mixed infections compared to qPCR. Microscopy demonstrated good sensitivity for P. falciparum but only moderate sensitivity for P. vivax and poor sensitivity for mixed infections, resulting in species misclassification and underdiagnosis. Such misdiagnosis leads to inappropriate treatment, ongoing transmission, and missed targeted elimination opportunities. The presence of qPCR-positive but microscopy-negative cases suggests submicroscopic infections, suboptimal slide preparation, and technician skill gaps. Enhancing diagnostic accuracy through ongoing training, quality assurance, and the integration of more sensitive RDTs is crucial to improving case management and supporting malaria control efforts in Dilla Zuria, Ethiopia. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3.